Form 4: Tandem Diabetes Care Executive Exercises Performance Stock Units and Disposes of Shares for Tax Obligations

Susan Morrison, EVP & Chief Admin. Officer of Tandem Diabetes Care, exercised performance stock units and disposed of shares to cover tax withholding requirements on February 25, 2025.

Summary

• On February 25, 2025, Susan Morrison, EVP & Chief Admin. Officer of Tandem Diabetes Care Inc., exercised performance stock units (PSUs) that were awarded under the company's 2013 Stock Incentive Plan.
• Specifically, 1,380 PSUs awarded on May 18, 2021, and 5,523 PSUs awarded on May 25, 2022, were exercised.
• Following the exercise of these PSUs, shares of common stock were withheld by Tandem Diabetes Care to satisfy tax withholding requirements.
• 395 shares were disposed of at a price of $33.34, and 1,632 shares were disposed of at a price of $33.34 to cover these tax obligations.
• After these transactions, Morrison directly owns 31,189 shares of Tandem Diabetes Care common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, which is common in publicly traded companies within the medical device industry. It reflects the standard practice of granting performance-based equity awards to align executive incentives with company performance.

Comparison to Industry Standards

• Executive compensation packages including performance stock units are common across the medical device industry.
• Companies like Medtronic, Abbott, and Dexcom also utilize equity-based compensation to incentivize their executives.
• The specific terms and conditions of the PSUs, such as the performance metrics and vesting schedules, would need to be compared to those of peer companies to assess their relative competitiveness.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, as it involves the exercise of previously granted equity awards and the disposal of shares to cover tax obligations.
• The filing provides transparency regarding executive compensation and stock ownership, which can be of interest to shareholders.

Key Dates